RAPP · Categories · Coverage
RAPP - Analyst coverage initiated
Rapport Therapeutics Inc. (RAPP) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for RAPP
- UBS initiated coverage on Rapport Therapeutics with a new price targetUBS initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $71.00
- Wolfe Research initiated coverage on Rapport Therapeutics with a new price targetWolfe Research initiated coverage of Rapport Therapeutics with a rating of Outperform and set a new price target of $50.00
- Guggenheim initiated coverage on Rapport Therapeutics with a new price targetGuggenheim initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $65.00
- William Blair initiated coverage on Rapport TherapeuticsWilliam Blair initiated coverage of Rapport Therapeutics with a rating of Outperform
- Leerink Partners initiated coverage on Rapport Therapeutics with a new price targetLeerink Partners initiated coverage of Rapport Therapeutics with a rating of Outperform and set a new price target of $52.00
- Raymond James initiated coverage on Rapport Therapeutics with a new price targetRaymond James initiated coverage of Rapport Therapeutics with a rating of Strong Buy and set a new price target of $66.00
- Wells Fargo initiated coverage on Rapport Therapeutics with a new price targetWells Fargo initiated coverage of Rapport Therapeutics with a rating of Overweight and set a new price target of $43.00
- BTIG Research initiated coverage on Rapport Therapeutics with a new price targetBTIG Research initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $47.00
- Truist initiated coverage on Rapport Therapeutics with a new price targetTruist initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $44.00
- H.C. Wainwright initiated coverage on Rapport Therapeutics with a new price targetH.C. Wainwright initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $31.00
- Citizens JMP initiated coverage on Rapport TherapeuticsCitizens JMP initiated coverage of Rapport Therapeutics with a rating of Mkt Outperform
- TD Cowen initiated coverage on Rapport TherapeuticsTD Cowen initiated coverage of Rapport Therapeutics with a rating of Buy
- Jefferies initiated coverage on Rapport Therapeutics with a new price targetJefferies initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $35.00
- Stifel initiated coverage on Rapport Therapeutics with a new price targetStifel initiated coverage of Rapport Therapeutics with a rating of Buy and set a new price target of $35.00